EcoDrugPlus

Isotocin Receptor-Like

Ensembl ID : ENSSTUG00000017738
Gene Symbol: LOC115150526
3 Cross references
185 Possible Orthologues:

Isotocin Receptor-Like

Ensembl ID : ENSSTUG00000034019
Gene Symbol: LOC115207890
3 Cross references
185 Possible Orthologues:

Kelch-Like Ech-Associated Protein 1

Ensembl ID : ENSSTUG00000038417
Gene Symbol: LOC115147367
3 Cross references
187 Possible Orthologues:

Kelch-Like Ech-Associated Protein 1

Ensembl ID : ENSSTUG00000044774
Gene Symbol: LOC115178771
3 Cross references
187 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSSTUG00000002560
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSSTUG00000028920
Gene Symbol: KIF5B
3 Cross references
262 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSSTUG00000014939
Gene Symbol: KIF5B
3 Cross references
262 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSSTUG00000012405
Gene Symbol: KIF5B
3 Cross references
262 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSSTUG00000006587
Gene Symbol: KIF5B
3 Cross references
262 Possible Orthologues:

Kinesin-Like Protein Kif11

Ensembl ID : ENSSTUG00000049647
Gene Symbol: LOC115153288
3 Cross references
196 Possible Orthologues:

Kinesin-Like Protein Kif11-B

Ensembl ID : ENSSTUG00000020947
Gene Symbol: LOC115193668
3 Cross references
196 Possible Orthologues:

Leukotriene A-4 Hydrolase-Like

Ensembl ID : ENSSTUG00000002935
Gene Symbol: LOC115198687
3 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).